Why the study?
Pulmonary arterial hypertension is mostly induced by excessive proliferation of pulmonary arterial smooth muscle cells through an undefined mechanism, prompting investigation into the function and mechanism of cervical sympathetic trunk transection on monocrotaline-induced PAH progression in rats.
Population
Rats with monocrotaline-induced pulmonary arterial hypertension
Comparison
Transection of the cervical sympathetic trunk vs PAH+sham group
Design
Experimental rat model study with transcriptome sequencing
Answers are grounded in this paper and cite their sources.
Sympathetic trunk transection effects in rat PAH models should not change practice; hypothesis-generating for neuromodulation targets in human disease.
Background Pulmonary arterial hypertension (PAH) is mostly induced by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs) with undefined mechanism. This study investigated the function and mechanism of transection of the cervical sympathetic trunk (TCST) on the progression of monocrotaline (MCT)-induced PAH in rats and explored the underlying mechanism. Methods A rat model of PAH was established by MCT injection. We evaluated the restoration of pulmonary architecture and hemodynamic parameters following TCST. Transcriptome sequencing (RNA-seq) was performed to identify key regulatory genes and signaling pathways that are particularly correlated with PASMC proliferation. The identified genes and pathways were further validated in the PAH model. Results TCST significantly attenuated pulmonary vascular remodeling and improved hemodynamic condition, as evidenced by reduced mean pulmonary arterial pressure (mPAP), right ventricular systolic pressure (RVSP), and right ventricular hypertrophy index (RVHI) compared to the PAH+sham group. RNA-seq analysis revealed that TCST suppressed calcium signaling and cell proliferation pathways, with downregulated DEGs enriched in immune responses, inflammatory responses, and the calcium signaling pathway. Differential expression analysis showed downregulation of the calcium pathway genes Adra1d and Tacr1 , as well as their transcriptional regulator Foxa3 . Further qPCR experiments confirmed decreased levels of Adra1d, Tacr1, Plcb1 , and Foxa3 . ELISA confirmed the inhibited expression of inositol trisphosphate (IP3), which directly regulate intracellular calcium concentration. Conclusions We explored the mechanism of TCST in ameliorating PAH by the suppression of the Foxa3/Adra1d-Tacr1 axis involved in calcium signaling, revealing a novel link between PAH and calcium-driven vascular remodeling, and a mechanistic basis for TCST as a potential therapeutic strategy for PAH.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: